Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 12:38 AM
NCT ID:
NCT01304667
Eligibility Criteria:
Inclusion Criteria:
1. Patients with primary squamous cell vulvar cancer except stage Ia disease regardless of the received treatment
2. Patients with recurrent squamous cell vulvar cancer, if the relapse was not only treated with a surgical excision.
3. Or alternatively, dependent on the decision of the participating center:
-Patients with primary or relapsed squamous cell vulvar cancer receiving radio- and/or chemotherapy for treatment regardless of nodal involvement.
4. Patients who were diagnosed with and treated for primary or relapsed vulvar cancer between 1998 and 2008
5. Women aged ≥ 18 years
Exclusion Criteria:
1. Patients with benign or precursor lesions (VIN - vulvar intraepithelial neoplasia) of the vulva
2. Patients with non-squamous neoplasia of the vulva (e.g. melanoma)
3. Patients with verrucous vulvar cancer
4. Patients with relapsed squamous cell vulvar cancer only receiving surgical excision for treatment.
5. Patients with secondary cancers if those interfered with the treatment of vulvar disease
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT01304667
Study Brief:
Protocol Section:
NCT01304667